Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Low and High CD8 Positive T cells in Multiple Sclerosis Patients.
Sphingosine-1-phosphate in chronic intestinal inflammation and cancer.
CNS-wide Sexually Dimorphic Induction of the Major Histocompatibility Complex 1 Pathway With Aging.
A qualitative study of the childbearing experience of women living with multiple sclerosis.
The Utility of Administrative Data for Surveillance of Comorbidity in Multiple Sclerosis: A Validation Study.
[The chronic form of tick-born encephalitis with a clinical manifestation of disseminated encephalomyelitis (case description).]
Development of a Standardized MRI Scoring Tool for CNS Demyelination In Children.
Early versus delayed treatment with laquinimod demonstrated significant reduction in risk of disability progression – Results of three-year ALLEGRO study in relapsing-remitting multiple sclerosis
Acute disseminated encephalomyelitis (ADEM) following a H3N3 parainfluenza virus infection in a pregnant asthmatic woman with respiratory failure.
Subject movement during multislice interleaved MR acquisitions: Prevalence and potential effect on MRI-derived brain pathology measurements and multicenter clinical trials of therapeutics for multiple sclerosis.
Histone deacetylase activity is required for human oligodendrocyte progenitor differentiation.
The new therapeutic landscape in multiple sclerosis: exciting times and new perspectives.
Simvastatin interferes with process outgrowth and branching of oligodendrocytes.
Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity.
The meninges: new therapeutic targets for multiple sclerosis.
Paroxysmal ataxia and dysarthria in multiple sclerosis.
Notch Signaling and T-Helper Cells in EAE/MS.
Evaluation of Inner Retinal Layers in Patients with Multiple Sclerosis or Neuromyelitis Optica Using Optical Coherence Tomography.
Structural and Metabolic Features of Two Different Variants of Multiple Sclerosis: A PET/MRI Study.
Disease-specific molecular events in cortical multiple sclerosis lesions.
Riboflavin Supplementation to Patients with Multiple Sclerosis does not Improve Disability Status nor is Riboflavin Supplementation Correlated to Homocysteine.
Assessment of immune functions and MRI disease activity in relapsing-remitting multiple sclerosis patients switching from natalizumab to fingolimod (ToFingo-Successor).
Work-related problems in multiple sclerosis: a literature review on its associates and determinants.
Sphingosine 1-Phosphate Receptor Modulators in Multiple Sclerosis.
Aquatic training in MS: neurotherapeutic impact upon quality of life.

Pages